For precision and ease of use, we performed an ROC analysis to determine an SFI cut-off of 4.45 to discriminate between high (B7-H3high) and low (B7-H3low) expression of B7-H3 on AML blasts. The gene discussed is CD276; the disease is acute myeloid leukemia.